
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions
Keywords: CDC; Center for Disease Control and Prevention; CF; Cystic fibrosis; CFTR; Cystic fibrosis transmembrane conductance regulator; IRT; Immunoreactive trypsinogen; NBS; Newborn screening; PKU; Phenylketonuria;